Silexion Therapeutics's market cap is currently $7.48M. The company's EPS TTM is $-19.982; its P/E ratio is ―; Silexion Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Silexion Therapeutics Earnings and Revenue History
